Free shipping on all orders over $ 500

JNJ-42041935

Cat. No. M8963

All AbMole products are for research use only, cannot be used for human consumption.

JNJ-42041935 Structure
Synonym:

JNJ42041935; HIF-PHD Inhibitor II

Size Price Availability Quantity
1mg USD 35  USD35 In stock
2mg USD 49  USD49 In stock
5mg USD 83  USD83 In stock
10mg USD 123  USD123 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

JNJ-42041935 was the most potent inhibitor of PHD2181–417 with a pIC50 value of 7.0 ± 0.03. JNJ-42041935 caused a concentration-dependent elevation of cellular HIF-1α and erythropoietin release in Hep3B cells. JNJ-42041935 (100 μmol/kg, once a day for 14 days) was effective in reversing inflammation-induced anemia.

Protocol (for reference only)
Cell Experiment
Cell lines Hep3B cells
Preparation method The potency of compounds for stabilization of intracellular HIF-1α and release of erythropoietin into the media was assessed in the human hepatoma cell line Hep3B. Cells were cultured in Dulbecco's modified Eagle's medium/high glucose (Invitrogen) supplemented with 10% fetal calf serum and 2 mM l-glutamine, 1% nonessential amino acids, 1 mM sodium pyruvate, 50 IU/ml penicillin, and 50 μg/ml streptomycin. A range of concentrations was incubated in 96-well plates with 30,000 cells/well for 24 h. Incubation media were collected, and cells were subsequently lysed for assessment of cellular HIF-1α content and erythropoietin concentration.
Concentrations 1 to 10 μM
Incubation time 24 h
Animal Experiment
Animal models Balb/C mice
Formulation
Dosages 30, 100, and 300 μmol/kg
Administration p.o.
Chemical Information
Molecular Weight 346.65
Formula C12H6ClF3N4O3
CAS Number 1193383-09-3
Solubility (25°C) DMSO ≥ 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Corcoran A, et al. Hippocampus. A role for prolyl hydroxylase domain proteins in hippocampal synaptic plasticity.

[2] Barrett TD, et al. Mol Pharmacol. Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor.

Related HIF Products
HIF-1α-IN-3 

HIF-1α-IN-3 is a hypoxia-selective HIF-1α inhibitor.

HIF-2α-IN-2 

HIF-2α-IN-2 is a hypoxia-inducible factors (HIF-2α) inhibitor, has an IC50 of 16 nM in scintillation proximity assay (SPA).

PRLX-93936 dihydrochloride 

PRLX-93936 dihydrochloride is a HIF-1α inhibitor with anticancer activity.

3-Aminobenzoic acid

3-Aminobenzoic acid is a hypoxia-inducible factor-1α (HIF-1α) inhibitor.

Steppogenin

Steppogenin is a potent inhibitor of HIF-1α and DLL4, with IC50 values of 0.56 and 8.46 μM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: JNJ-42041935, JNJ42041935; HIF-PHD Inhibitor II supplier, HIF, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.